These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


388 related items for PubMed ID: 28107193

  • 1. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.
    Guan H, Liu C, Fang F, Huang Y, Tao T, Ling Z, You Z, Han X, Chen S, Xu B, Chen M.
    Oncotarget; 2017 Feb 28; 8(9):14693-14707. PubMed ID: 28107193
    [Abstract] [Full Text] [Related]

  • 2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY, Xue M, Zhang QC, Su CF.
    Oncotarget; 2017 Feb 28; 8(9):15507-15519. PubMed ID: 28099945
    [Abstract] [Full Text] [Related]

  • 3. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
    Wang D, Lu G, Shao Y, Xu D.
    Biomed Pharmacother; 2018 Mar 28; 99():334-339. PubMed ID: 29353209
    [Abstract] [Full Text] [Related]

  • 4. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
    Wu G, Liu A, Zhu J, Lei F, Wu S, Zhang X, Ye L, Cao L, He S.
    Oncotarget; 2015 Oct 06; 6(30):28882-94. PubMed ID: 26337084
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.
    Fan D, Ren B, Yang X, Liu J, Zhang Z.
    J Exp Clin Cancer Res; 2016 Nov 15; 35(1):177. PubMed ID: 27846906
    [Abstract] [Full Text] [Related]

  • 6. miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3β.
    Song XL, Huang B, Zhou BW, Wang C, Liao ZW, Yu Y, Zhao SC.
    Biomed Pharmacother; 2018 Mar 15; 99():369-374. PubMed ID: 29358129
    [Abstract] [Full Text] [Related]

  • 7. Over-expression of microRNA-940 promotes cell proliferation by targeting GSK3β and sFRP1 in human pancreatic carcinoma.
    Yang HW, Liu GH, Liu YQ, Zhao HC, Yang Z, Zhao CL, Zhang XF, Ye H.
    Biomed Pharmacother; 2016 Oct 15; 83():593-601. PubMed ID: 27459115
    [Abstract] [Full Text] [Related]

  • 8. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
    Mu Y, Zhang L, Chen X, Chen S, Shi Y, Li J.
    Biosci Rep; 2019 Jun 28; 39(6):. PubMed ID: 31072914
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
    Ba S, Xuan Y, Long ZW, Chen HY, Zheng SS.
    Cell Physiol Biochem; 2017 Jun 28; 42(5):1920-1933. PubMed ID: 28772260
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-197 Promotes Metastasis of Hepatocellular Carcinoma by Activating Wnt/β-Catenin Signaling.
    Hu Z, Wang P, Lin J, Zheng X, Yang F, Zhang G, Chen D, Xie J, Gao Z, Peng L, Xie C.
    Cell Physiol Biochem; 2018 Jun 28; 51(1):470-486. PubMed ID: 30453289
    [Abstract] [Full Text] [Related]

  • 11. Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway.
    Mao XW, Xiao JQ, Li ZY, Zheng YC, Zhang N.
    Exp Mol Med; 2018 Jan 19; 50(1):e429. PubMed ID: 29350680
    [Abstract] [Full Text] [Related]

  • 12. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
    Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang Z, Li R, Zhang Z, Li Z, Dong S, Wang Y, Xue Y, Yang J, Tan Q, Wang Z, Song X.
    Oncotarget; 2015 May 10; 6(13):10964-77. PubMed ID: 25844602
    [Abstract] [Full Text] [Related]

  • 13. HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/β-catenin signaling pathway.
    Zang B, Huang G, Wang X, Zheng S.
    Int J Clin Exp Pathol; 2015 May 10; 8(10):13687-94. PubMed ID: 26722596
    [Abstract] [Full Text] [Related]

  • 14. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
    Li T, Jian X, He H, Lai Q, Li X, Deng D, Liu T, Zhu J, Jiao H, Ye Y, Wang S, Yang M, Zheng L, Zhou W, Ding Y.
    J Exp Clin Cancer Res; 2018 Sep 25; 37(1):238. PubMed ID: 30253791
    [Abstract] [Full Text] [Related]

  • 15. Long noncoding RNA SNHG12 promotes cell proliferation and activates Wnt/β-catenin signaling in prostate cancer through sponging microRNA-195.
    Song J, Wu X, Ma R, Miao L, Xiong L, Zhao W.
    J Cell Biochem; 2019 Aug 25; 120(8):13066-13075. PubMed ID: 30945357
    [Abstract] [Full Text] [Related]

  • 16. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X, Song X, Yue W, Chen D, Yu J, Yao Z, Zhang L.
    Oncotarget; 2015 Jun 20; 6(17):15022-34. PubMed ID: 25909283
    [Abstract] [Full Text] [Related]

  • 17. miR-191 Inhibition Induces Apoptosis Through Reactivating Secreted Frizzled-Related Protein-1 in Cholangiocarcinoma.
    Kang PC, Leng KM, Liu YP, Liu Y, Xu Y, Qin W, Gao JJ, Wang ZD, Tai S, Zhong XY, Cui YF.
    Cell Physiol Biochem; 2018 Jun 20; 49(5):1933-1942. PubMed ID: 30235453
    [Abstract] [Full Text] [Related]

  • 18. [Mechanism of HOXC6 promoting the progression of prostate cancer by activating the SFRP1/Wnt/β-catenin signaling pathway].
    Zheng YJ, Li WM, Zheng LC, Zhou YF, Wang J, Xia WM, Ye WJ, Yu JS.
    Zhonghua Nan Ke Xue; 2024 Jul 20; 30(7):579-587. PubMed ID: 39212391
    [Abstract] [Full Text] [Related]

  • 19. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling.
    Ren W, Wang D, Li C, Shu T, Zhang W, Fu X.
    Biomed Pharmacother; 2018 Dec 20; 108():467-475. PubMed ID: 30241050
    [Abstract] [Full Text] [Related]

  • 20. miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway.
    Liu S, Wang Q, Liu Y, Xia ZY.
    J Biosci; 2019 Sep 20; 44(4):. PubMed ID: 31502580
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.